跳至主要内容
临床试验/NCT07679087
NCT07679087尚未招募不适用

Study of the Frequency and Characteristics of Pain Symptoms in Restless Legs Syndrome

University Hospital, Clermont-Ferrand1 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2026年7月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
1,000
试验地点
1
主要终点
Pain evaluation according to the Brief Pain Inventory (PBI)

研究概览

简要总结

Restless Legs Syndrome (RLS) is a neurological disorder affecting between 4% and 29% of adults. It is characterized by an urge to move the legs or other parts of the body, often accompanied by unpleasant and sometimes painful sensations. The pathophysiology of RLS, whether associated with pain or not, remains poorly understood, and only a limited number of studies have specifically investigated this aspect.

The aim of this study is to determine the prevalence of the painful component of symptoms in a large cohort of patients with RLS, to further characterize its clinical features, and to assess its impact on patients' quality of life. This work could improve the identification of patients experiencing pain, enhance our understanding of pain characteristics in RLS, and help optimize patient management. Furthermore, in the context of emerging therapeutic approaches such as neuromodulation, a better characterization of pain in RLS may contribute to the development and evaluation of new treatment strategies. This is particularly relevant given the high prevalence of RLS and its substantial impact on patients' quality of life.

Participants will be recruited either through their neurologist during routine follow-up visits at the Neurology Department of Clermont-Ferrand University Hospital or through the France Ekbom Association. Individuals interested in participating will be provided with access to the online questionnaire via a QR code or a dedicated web link. One thousand patients will be include in this study (RIPH type 3). The online questionnaire is expected to take approximately 30 minutes to complete. It includes the collection of demographic data (age, sex, lifestyle factors, weight, height, employment status, comorbidities, and dietary habits), as well as questions regarding the patient's medical history and sleep habits.

The questionnaire also includes validated instruments assessing sleep, pain, RLS severity, anxiety and depression, and quality of life.

At the end of the questionnaire, participants will be invited to take part in an optional ancillary study aimed at validating the French translation of the Restless Legs Syndrome Quality of Life questionnaire (RLS-QOL). Participants who agree to participate will complete the questionnaire once at baseline and will subsequently receive an email reminder to complete it a second time two weeks later. This test-retest procedure will be used to assess the reproducibility of the French-adapted version of the questionnaire.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female participants aged 18 years or older.
  • Diagnosis of Restless Legs Syndrome (RLS) according to the criteria of the International Classification of Sleep Disorders, Third Edition (ICSD-3).
  • French-speaking.

排除标准

  • Patient under guardianship, curatorship, or legal protection measures.
  • Patient who has never had an appointment with a neurologist as part of their SJSR care pathway.

结局指标

主要结局

Pain evaluation according to the Brief Pain Inventory (PBI)

时间窗: at day 0

次要结局

  • Pain characteristics using the DN4 questionnaire(at day 0)
  • RLS severity using the International Restless Legs Syndrome Rating Scale (IRLS)(at day 0)
  • Biopsychosocial dimensions of pain according to the Pain Catastrophizing Scale (PCS).(at day 0)
  • Anxiety and depression using the Hospital Anxiety and Depression Scale (HADS)(at day 0)
  • Quality of life using the EQ-5D-5L(at day 0)
  • Daytime sleepiness using Epworth Sleepiness Scale (ESS).(at day 0)
  • RLS-specific quality of life using the Restless Legs Syndrome Quality of Life questionnaire (RLS-QOL).(at day 0)
  • Fibromyalgia using the FIRST (Fibromyalgia Rapid Screening Tool)(at day 0)

研究者

发起方
University Hospital, Clermont-Ferrand
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验